Caspian Oliai, MD, MS, on Making Allo-Transplant Safer for Older Patients
The medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center discussed results from a phase 1b trial for allo-HCT alternative Orca-T that he presented at Tandem’s 2024 conference.